# OnCo record paper-goya-obinutuzumab-vs-rituximab-chop-dlbcl-jco-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-goya-obinutuzumab-vs-rituximab-chop-dlbcl-jco-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-goya-obinutuzumab-vs-rituximab-chop-dlbcl-jco-2017" ;
  schema:name "Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large B-cell lymphoma"@en ;
  schema:alternateName "GOYA"@en, "Vitolo 2017"@en ;
  schema:description "A newer antibody against the same target did not improve first-line treatment of the commonest aggressive lymphoma, although it had improved treatment of two other B-cell cancers."@en ;
  schema:url <https://onco.cc/key-papers/paper-goya-obinutuzumab-vs-rituximab-chop-dlbcl-jco-2017/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2017.73.3402>, <https://pubmed.ncbi.nlm.nih.gov/28796588/>, <https://europepmc.org/article/MED/28796588> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2017.73.3402> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Vitolo U, Trněný M, Belada D, et al." ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/obinutuzumab/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/prednisone/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:terms <https://onco.cc/terms/r-chop/>, <https://onco.cc/terms/cell-of-origin/> ;
  onco:trials <https://onco.cc/trials/goya/>, <https://onco.cc/trials/gallium/> ;
  onco:people <https://onco.cc/people/laurie-sehn/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-negative-results/>, <https://onco.cc/bottlenecks/b-biomarker-validation/> ;
  onco:journals <https://onco.cc/journals/jco/> .